Acadia Pharmaceuticals

Acadia is transforming scientific promise into meaningful innovations. See our community guidelines:

[Acadia Pharmaceuticals @AcadiaPharma]

We are pleased to welcome Carl Segerstrom as our new Chief People Officer. Carl will lead Acadia's global people and culture strategy and joins our executive leadership team with more than 25 years of global HR leadership in biopharma.

Learn more: https://t.co/eiDHEYc9ST

[Acadia Pharmaceuticals @AcadiaPharma]

Today, we announced that CHMP has adopted a positive opinion recommending marketing authorization for our treatment for the neurobehavioral symptoms of #RettSyndrome in adults and pediatric patients 5 years and older in the EU.

Learn more: https://t.co/DOCxabpXV6

[Acadia Pharmaceuticals @AcadiaPharma]

We’re looking forward to joining clinicians, researchers, and Rett organizations as we present our latest data in #RettSyndrome at the upcoming @RettSyndrome Scientific Meeting.

Learn more: https://t.co/qrF54mIA1V.

[Acadia Pharmaceuticals @AcadiaPharma]

June is Alzheimer’s & Brain Awareness Month. Founded by the @alzassociation, this month is dedicated to raising awareness about #AlzheimersDisease, a condition that impacts 6M+ Americans.

Discover ways to promote brain health and join the fight: https://t.co/3F5CYRQ1X4. #ENDALZ

[Acadia Pharmaceuticals @AcadiaPharma]

We’re traveling to Washington D.C. this week for the @PMDAlliance #ATMRD2026 Congress where we’ll be sharing our latest findings in #ParkinsonsDisease psychosis and #EssentialTremor. Learn more: https://t.co/KfY5Y7GbcF.

[Acadia Pharmaceuticals @AcadiaPharma]

At Acadia, our purpose extends beyond what we do. It is reflected in how we do it.

We are proud to share our first #CorporateResponsibility Report, highlighting how we support patients, empower our people, and strengthen our communities.

Learn more: https://t.co/ngZZlIrpWS

[Acadia Pharmaceuticals @AcadiaPharma]

We look forward to joining the @ASCPorg annual meeting in Miami as we share our latest findings in Lewy body dementia psychosis and #ParkinsonsDisease psychosis.

Learn more and register here: https://t.co/QE5t6Gt9bu. #ASCP2026

[Acadia Pharmaceuticals @AcadiaPharma]

Heading to the 7th @WorldPDCongress this weekend?

We’re excited to share our latest findings in Lewy body dementia psychosis and #ParkinsonsDisease psychosis while engaging in conversations driving progress for patients. Learn more: https://t.co/gD92saaHaL.

#wpc2026

[Acadia Pharmaceuticals @AcadiaPharma]

We’re proud to bring our latest findings in #RettSyndrome to
#ISPORAnnual this week in Philadelphia. Learn more and register here: https://t.co/GvA0PaJGIh.

[Acadia Pharmaceuticals @AcadiaPharma]

Today, we shared our Q1 2026 #earnings results. Read our $ACAD financial summary and key updates here: https://t.co/lUhkeY15jx.

[Acadia Pharmaceuticals @AcadiaPharma]

We’re looking forward to participating in upcoming #investor conferences, including the @BofA_Business Securities 2026 Health Care Conference and the 2026 @rbccm Capital Markets Global Healthcare Conference.

Learn about our participation: https://t.co/3i4mnkNpCn. $ACAD

[Acadia Pharmaceuticals @AcadiaPharma]

Where neurology comes together.

As #AAN2026 continues, our team is energized by the opportunity to connect with colleagues across the field and engage in thoughtful scientific exchange throughout the meeting.

[Acadia Pharmaceuticals @AcadiaPharma]

At 2026 @AANMember Annual Meeting we’ll be presenting 5 scientific abstracts and posters featuring our latest data and insights from ongoing research efforts in #RettSyndrome, #ParkinsonsDisease, and #EssentialTremor.

Learn more: https://t.co/6qwgM80GDF

[Acadia Pharmaceuticals @AcadiaPharma]

We’re heading to Chicago this weekend for the 2026 @AANMember Annual Meeting.

We’re looking forward to sharing our recent findings in #RettSyndrome, #ParkinsonsDisease, and #EssentialTremor.

Learn more: https://t.co/6Aa1YKZqHn.

[Acadia Pharmaceuticals @AcadiaPharma]

Today we announced that a new powder formulation for the first and only approved therapy for #RettSyndrome patients is now broadly available, offering patients and their families flexibility and choice in their treatment.
Learn more: https://t.co/hsP5lrRKFk.

[Acadia Pharmaceuticals @AcadiaPharma]

Heading to Anaheim this week for the @PALTmed Annual Conference? We’re looking forward to sharing our recent learnings in #ParkinsonsDisease and diving into insights shaping the future of post‑acute and long‑term care. Learn more: https://t.co/v109P0s2Mj. #PALTC26

[Acadia Pharmaceuticals @AcadiaPharma]

We’re on the ground in Pittsburgh this week for the National Association of Pediatric Nurse Practitioners 47th National Conference on Pediatric Health Care.

If you’re here too, make sure to visit us at booth 408 to learn more about our latest data in #RettSyndrome!

[Acadia Pharmaceuticals @AcadiaPharma]

Will you be attending the 47th National Conference on Pediatric Health Care this week? Stop by Booth 408 to connect with our team and learn more about our data on #RettSyndrome.

Learn more about the event here: https://t.co/ewkkQ1Fg84.

[Acadia Pharmaceuticals @AcadiaPharma]

We were honored to have the opportunity to ring the Opening Bell at @NasdaqExchange as we celebrated multiple Acadia milestones, including surpassing $1B in annual revenue for the first time in 2025.

We look forward to continuing to transform scientific promise into therapies.

[Nasdaq Exchange @NasdaqExchange]

.@acadiapharma is advancing therapies and redefining care through meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world.

Proud to be your exchange partner, $ACAD! #NasdaqListed

[Acadia Pharmaceuticals @AcadiaPharma]

We’re looking forward to participating in the upcoming @Stifel 2026 Virtual CNS Forum.

Learn about our participation: https://t.co/MTYaJftRBi $ACAD